Expand all sections

Filgotinib

Extended indication Behandeling van matige tot ernstige reumatoïde artritis bij volwassen patiënten, die onvoldoende rea
Therapeutic value Possible equal value
Total cost 2,300,000.00
Registration phase Registration application pending

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information